Search results
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT)...
Market Watch· 1 day agoSensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global ...
Why the Westminster Dog Show Made Me Appreciate Mutts
Time via Yahoo News· 2 days agoWhat it means, in practice, is that show dogs are inbred. Inbreeding is fairly common among all...
Researchers uncover SNUPN gene responsible for a new muscular disorder
Medical Xpress· 3 days agoA study, published in Nature Communications, sheds light on a newly identified subtype of muscular...
These are the top 12 fertility clinics in the Northeast region of the US
Newsweek· 6 days agoNewsweek, in partnership with Statista, recently published its second annual ranking of America's...
FDA rejects Abeona cell therapy, asks for more manufacturing data
BioPharma Dive via Yahoo Finance· 4 days agoEB is typically managed by supportive care. Recently, genetic medicines have emerged as a...
Abeona shares tumble as FDA declines to approve skin disorder treatment
Reuters via Yahoo News· 5 days agoThe drug developer is seeking approval for the treatment in patients with recessive dystrophic...
White deer hailed as ‘symbol of our community’
The Times of Northwest Indiana· 6 days agoCROWN POINT – If you’ve ever lost a pet, perhaps you can relate to those who gathered outside First United Methodist Church Crown Point Sunday. People...
FDA Seeks More Information About RDEB Rx Under Review
Medscape· 2 days agoPz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds.
Abeona Therapeutics (NASDAQ:ABEO) Downgraded to “Sell” at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com cut shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Abeona Therapeutics Trading Down 53.7 ...
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $52.13 Average PT from Analysts
ETF DAILY NEWS· 1 day agoShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are presently covering the firm, Marketbeat ...